8-K ·Filed Apr 14, 2026

VREOF

Vireo Growth Inc.
MIXED
Impact 7/10
Horizonweeks Processed5mo ago SEC0001104659-26-043175
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ◆ Mixed

Traders should monitor the integration of Hawthorne operations and potential margin improvements from supply chain optimization. The significant dilution may pressure the stock short-term, but long-term value depends on successful integration and realization of synergies. Watch for Hagedorn's influence on strategy as the new board nominee.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
VREOF ▼ -26.30% at T+60d
NEUTRAL call ✗ call lost -26.30% · α vs SPY -34.43% · entry $13.50 → $9.95
Entry anchored
Apr 14, 2026
via day open
T+1d
-2.89%
call -2.89% · α -3.13%
$13.11
settled 6mo ago
T+5d
+10.44%
call +10.44% · α +8.83%
$14.91
settled 5mo ago
T+20d
-7.78%
call -7.78% · α -13.83%
$12.45
settled 5mo ago
T+60d
-26.30%
call -26.30% · α -34.43%
$9.95
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Vireo Growth Inc. completed the acquisition of The Hawthorne Gardening Company from Scotts Miracle-Gro, issuing 213 million shares and warrants for 80 million shares. The deal strengthens Vireo's balance sheet with $110 million in cash and net working capital, but the stock will be diluted by approximately 14% immediately and up to 19% if all warrants are exercised.

Key Financial Metrics

EPS
$-0.01
est $0.01 · -200.0%
Revenue
$104.5M
est $109.2M · -4.3% · +317.7% YoY
Rating
strong miss
Gross Margin
54.4%
Deal Value
$127.8M
Deal Type
acquisition
Dilution
14%

Key Facts

  • Acquired The Hawthorne Gardening Company from Scotts Miracle-Gro
  • Issued 213 million shares and warrants for 80 million shares as consideration
  • Deal brings $110 million in cash and net working capital to Vireo
  • Immediate dilution of approximately 14% to existing shareholders
  • Potential dilution up to 19% if all warrants are exercised
  • Nominated Scotts executive Chris Hagedorn for Vireo's Board of Directors

Financial Impact

$110 million in cash and net working capital

cashworking capitaldilution

Risk Factors

  • Dilution from 213 million share issuance and potential 80 million from warrants
  • Integration challenges of Hawthorne operations
  • Dependence on successful realization of supply chain synergies

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-043175
Document: tm2611658d1_ex10-1.htm0001104659-26-043175
Document: tm2611658d1_ex4-1.htm0001104659-26-043175
Document: tm2611658d1_8k.htm0001104659-26-043175
Document: tm2611658d1_ex99-1.htm0001104659-26-043175
Document: 0001104659-26-043175-index-headers.html0001104659-26-043175
Document: 0001104659-26-043175-index.html0001104659-26-043175
8-K Data (Synthetic)0001104659-26-043175
13 reports for VREOF
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +18.71%Jun 18, 2026
Filters
Rows
Reports for VREOF — sortable, filterable
TypeNow
Aug 18, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$10.97 $12.11▲ +10.39%▲ +11.91%$9.61 (−12.40%)
Aug 11, 2026
7w ago
8-K
MIXED ★ 6/10
$10.64 $12.12▲ +13.91%▲ +14.97%$9.61 (−9.68%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$10.01 $10.84▲ +8.29%▲ +7.69%$9.61 (−4.00%)
Jul 30, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$9.44 $10.60▲ +12.29%▲ +9.30%$9.61 (+1.80%)
Jul 27, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$9.70 $10.89▲ +12.27%▲ +8.97%$9.61 (−0.93%)
Jun 18, 2026
15w ago
8-K
BULLISH ★ 6/10
$10.42 $9.80▼ −5.95%▼ −5.64%$9.61 (−7.77%)
Jun 11, 2026
16w ago
8-K
MIXED ★ 5/10
$12.46 $10.02▼ −19.58%▼ −20.84%$9.61 (−22.87%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$12.90 $9.82▼ −23.88%▼ −27.77%$9.61 (−25.50%)
May 29, 2026
18w ago
8-K
MIXED ★ 6/10
$13.05 $9.99▼ −23.47%▼ −22.17%$9.61 (−26.34%)
May 12, 2026
20w ago
8-K
BEARISH ★ 7/10
$12.09 $12.90▼ −6.70%▼ −8.43%$9.61 (+20.51%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (38h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access